Upperton appoint Philip Payne as Chief Commercial Officer
Upperton Pharma Solutions continues growth with the appointment of Philip Payne as Chief Commercial Officer.
Upperton Pharma Solutions is a Pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with more than twenty years of experience in the development of pharmaceutical dosage forms.
We offer our clients an extensive range of services, from early feasibility to dosage form development and clinical trial manufacturing.
We stand out as a CDMO offering unparalleled service. Our defining traits lie in our adaptability and nimbleness, allowing us to swiftly align with your evolving needs.
Your molecule reigns supreme. We pledge a commitment to prioritising your project, never relegating it to the bottom of a list.
Upperton Pharma Solutions continues growth with the appointment of Philip Payne as Chief Commercial Officer.
Upperton Pharma Solutions has announced a £5million investment to expand operations into small-scale sterile fill-finish.
What a year 2023 has been. A year of remarkable growth and achievements, award-winning, and
As a leading Contract, Development and Manufacturing Organisation (CDMO) our defining traits lie in our adaptability and nimbleness, enabling rapid product introduction.
Through a science-led approach we align to your drug development needs from pre-clinical to late phase commercial manufacture.
With more than 25 years of experience, count on us to navigate the complexities of your project with precision, expertise and our unique approach to project delivery.
Supporting you from feasibility to market.
Flexible and nimble, adapting to your project needs.
Our extensive expertise encompasses the development, scale-up, manufacturing, and rigorous testing of oral, pulmonary, and nasal drug products.
Our flexibility ensures that we can problem-solve, meet your timescales, and deliver solutions that meet patient targets.
Albert Einstein Centre, Nottingham Science Park, Nottingham, UK NG7 2TN,
Phone: +44 (0) 115 855 7050
Email: contact@upperton.com
Copyright © 2024 Upperton Limited. All rights reserved.